Not checkedNot checked for notices yet.
Clinical characteristics and outcome of <it>Penicillium marneffei</it> infection among HIV-infected patients in northern Vietnam
Larsson Mattias, Nguyen Lien Ha, Wertheim Heiman FL and 7 more
AIDS Research and Therapy · 2012
doi:10.1186/1742-6405-9-24 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Objective</p> <p>This study reports the clinical characteristics and outcome of HIV-associated <it>Penicilliummarneffei</it> infection in northern Vietnam.</p> <p>Methods</p> <p>We conducted a retrospective chart review of all patients with laboratory confirmed <it>Penicilliummarneffei</it> infection admitted to the National Hospital for Tropical Diseases in Hanoi, Vietnam, between July 2006 and September 2009.</p> <p>Results</p> <p>127 patients with <it>P. marneffei</it> infection were identified. All were HIV-infected; median CD4+ T-cell count was 24 cells/μl (IQR:12-48); 76% were men. Common clinical features were fever (92.9%), skin lesions (82.6%), hepatomegaly (61.4%), lymphadenopathy (40.2%), weight loss (59.1%) and cough (49.6%). Concurrent opportunistic infections were present in 22.0%; half of those had tuberculosis. Initial treatment regimens were: itraconazole or ketoconazole capsule (77.2%), amphotericin B (20.5%), and fluconazole (1.6%). In-hospital mortality was 12.6% and showed no significant difference in patients treated with itraconazole (or ketoconazole) and amphotericin B (p = 0.43). Dyspnea, ascites, and increased LDH level were independent predictors of mortality. No seasonality was observed.</p> <p>Conclusion</p> <p>The clinical features, treatments and outcomes of HIV-associated <it>P. marneffei</it> infection in northern Vietnam are similar to those reported in other endemic regions. Dyspnea was an important predictor of mortality. More patients were treated with itraconazole than amphotericin B and no significant difference in treatment outcome was observed. It would be of clinical value to compare the efficacy of oral itraconazole and amphotericin B in a clinical trial.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.